Heron Therapeutics
HRTX
#10276
Rank
โ‚น4.45 B
Marketcap
โ‚น23.40
Share price
-4.39%
Change (1 day)
-75.36%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2026 (TTM): -โ‚น17.27

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น17.61. In 2025 the company made an earnings per share (EPS) of -โ‚น11.12 a decrease over its 2024 EPS that were of -โ‚น8.34.

EPS history for Heron Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น17.2755.27%
2025-โ‚น11.1233.33%
2024-โ‚น8.34
2022-โ‚น160.32-23.11%
2021-โ‚น208.51-10%
2020-โ‚น231.67-0%
2019-โ‚น231.671.21%
2018-โ‚น228.89
2016-โ‚น421.6554.76%
2015-โ‚น272.451.73%
2014-โ‚น267.82-16.23%
2013-โ‚น319.7191.67%
2012-โ‚น166.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
-โ‚น113.98 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
โ‚น32.43-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น240.02-1,463.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
-โ‚น0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
-โ‚น620.89 3,426.32%๐Ÿ‡บ๐Ÿ‡ธ USA